Columbus Circle Investors »

Denali Therapeutics shares owned by Columbus Circle Investors

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Columbus Circle Investors from 13F filings

Historical chart of Columbus Circle Investors investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Columbus Circle Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Columbus Circle Investors

Quarter filed Position value Share count Share price at filing
2020-12-31 $7.0M 84k 83.77

More positions owned by Columbus Circle Investors

Zendesk
SVB Financial (SIVBQ)
Nuance Communications
Horizon Therapeutics Pub L SHS
Inspire Med Sys (INSP)
Visteon Corp Com New (VC)
Insulet Corporation (PODD)
Anaplan
Ambarella SHS (AMBA)
Deckers Outdoor Corporation (DECK)
Littelfuse (LFUS)
Floor & Decor Hldgs Cl A (FND)
Snap Cl A (SNAP)
Cree
Ringcentral Cl A (RNG)

View all positions for Columbus Circle Investors

Top funds holding Denali Therapeutics

BlackRock
Baillie Gifford & Co
Vanguard Group
Wellington Management Company
Capital Research Global Investors
FMR
Temasek Holdings
Crestline Management
State Street Corporation
Ubs Global Asset Management Americas
Baker Bros. Advisors
Alliancebernstein
Geode Capital Management
T. Rowe Price Associates
Camber Capital Management

View all funds holding Denali Therapeutics